SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Stelios P.)
 

Sökning: WFRF:(Stelios P.) > In situ pneumococca...

In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector

Li, Yi (författare)
The State University of New York
Beitelshees, Marie (författare)
The State University of New York
Fang, Lei (författare)
The State University of New York
visa fler...
Hill, Andrew (författare)
Abcombi Biosciences Inc.
Ahmadi, Mahmoud Kamal (författare)
The State University of New York
Chen, Mingfu (författare)
The State University of New York
Davidson, Bruce A (författare)
The State University of New York
Knight, Paul (författare)
The State University of New York
Smith, Randall J (författare)
The State University of New York
Andreadis, Stelios T (författare)
The State University of New York
Hakansson, Anders P (författare)
Lund University,Lunds universitet,Experimentell infektionsmedicin, Malmö,Forskargrupper vid Lunds universitet,Experimental Infection Medicine, Malmö,Lund University Research Groups,The State University of New York
Jones, Charles H (författare)
The State University of New York
Pfeifer, Blaine A (författare)
The State University of New York
visa färre...
The State University of New York Abcombi Biosciences Inc (creator_code:org_t)
American Association for the Advancement of Science (AAAS), 2016
2016
Engelska.
Ingår i: Science Advances. - : American Association for the Advancement of Science (AAAS). - 2375-2548. ; 2:7
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The type and potency of an immune response provoked during vaccination will determine ultimate success in disease prevention. The basis for this response will be the design and implementation of antigen presentation to the immune system. Whereas direct antigen administration will elicit some form of immunological response, a more sophisticated approach would couple the antigen of interest to a vector capable of broad delivery formats and designed for heightened response. New antigens associated with pneumococcal disease virulence were used to test the delivery and adjuvant capabilities of a hybrid biological-biomaterial vector consisting of a bacterial core electrostatically coated with a cationic polymer. The hybrid design provides (i) passive and active targeting of antigen-presenting cells, (ii) natural and multicomponent adjuvant properties, (iii) dual intracellular delivery mechanisms, and (iv) a simple formulation mechanism. In addition, the hybrid format enables device-specific, or in situ, antigen production and consolidation via localization within the bacterial component of the vector. This capability eliminates the need for dedicated antigen production and purification before vaccination efforts while leveraging the aforementioned features of the overall delivery device. We present the first disease-specific utilization of the vector toward pneumococcal disease highlighted by improved immune responses and protective capabilities when tested against traditional vaccine formulations and a range of clinically relevant Streptococcus pneumoniae strains. More broadly, the results point to similar levels of success with other diseases that would benefit from the production, delivery, and efficacy capabilities offered by the hybrid vector.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Nyckelord

Journal Article

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy